NCT05871242View on ClinicalTrials.gov

Study to Investigate the Treatment Benefit of Probiotic Lactobacillus Crispatus M247 in Women Undergoing Homologous Level 2 Assisted Reproductive Technology (ART) Procedures

NACompletedINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

January 10, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

June 30, 2022

Conditions

Fertility Issues

Interventions

DIETARY_SUPPLEMENT

Probiotic Lactobacillus crispatus M247

Patient who have received probiotic Lactobacillus crispatus M247

Trial Locations (1)

Unknown

ART center, Hospital of Conegliano, Treviso

All Listed Sponsors

collaborator

Treviso Regional Hospital

NETWORK

lead

Dr. Amjad Khan

OTHER

NCT05871242 - Study to Investigate the Treatment Benefit of Probiotic Lactobacillus Crispatus M247 in Women Undergoing Homologous Level 2 Assisted Reproductive Technology (ART) Procedures | Biotech Hunter | Biotech Hunter